Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shang‐Hsuan Peng
Observed name:
Shang-Hsuan Peng
Institution:
National Taiwan University Hospital
Observed institution:
National Taiwan University Hospital
ORCID:
0000-0002-5260-9585
Observed ORCID:
0000-0002-5260-9585
OpenAlex ID:
A5103108661
PARP inhibitor maintenance takes advantages in advanced epithelial ovarian cancer but May show a negative impact while recurrence occurs: a multi-center retrospective study in Taiwan
2026
·
Wei-Ting Chao
, Yu-Wen Sung
, et al.
·
Journal of Gynecologic Oncology
·
12
PDF
Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis
2023
·
Shang‐Hsuan Peng
, Ching‐Hung Lin
, et al.
·
Cancer Medicine
·
4
PDF
Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline mutation of MSH6: A case report
2022
·
Shang-Hsuan Peng
, Bang-Bin Chen
, et al.
·
Frontiers in Immunology
·
4
Uncommon Presentation of Combined Graves' Disease and Pulmonary Embolism in a 32-year-old Woman
2019
·
Shuyu Tang
, Shang‐Hsuan Peng
, et al.
·
內科學誌
·
3
Immune-related Neuromuscular Junction Disorder after Immune Checkpoint Inhibitor Treatment
2022
·
Shang-Hsuan Peng
, Yu-Yun Shao
·
Journal of Cancer Research and Practice
·
1
Abstract 4544: Immunotherapy with chemotherapy provides superb pathologic complete response rate in chemotherapy-resistant metaplastic carcinoma of breast
2025
·
I-Chun Chen
, Shang-Hsuan Peng
, et al.
·
Cancer Research
Induction immunotherapy-based regimens followed by palliative CCRT may lead to conversion surgery in selected patients and boost survival for stage IV ESCC.
2024
·
Jo-Pai Chen
, Wei-Chen Lu
, et al.
·
Journal of Clinical Oncology
PDF
Different efficacy of pembrolizumab in overall survival between Asians and non-Asians with advanced cancers: A systematic review and meta-regression analysis.
2023
·
Shang-Hsuan Peng
, Ching-Hung Lin
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
8
Citation count:
24
H-index:
3
I10-index:
1
Year
Topic
Type